Renard-Penna Raphaële, Gauthé Mathieu
Academic Departments of Radiology. Tenon and Pitié-Salpétrière Hospitals. AP-HP, Sorbonne Universités. GRC5. ONCOTYPE-Uro. Institut Universitaire de Cancérologie. Paris. France.
Médecine Nucléaire. Hôpital Tenon AP-HP. Institut Universitaire de Cancérologie. Health Economics Research Unit - APHP. INSERM UMR 1123Sorbonne Universités. Paris. France.
Arch Esp Urol. 2019 Mar;72(2):150-156.
The major goal of prostate cancer imaging in the next decade will be more accurate disease diagnostic, characterization and staging through the synthesisof anatomic, functional and molecular imaging.Changes are happening regarding the use of prostate MRI for evaluating primary prostate cancer and PET CT for the staging and recurrence staging of prostate cancer.This review presents a multidisciplinary perspective of the role of prostate MRI and molecular imaging in prostate cancer.
未来十年前列腺癌成像的主要目标将是通过整合解剖学、功能和分子成像，实现更准确的疾病诊断、特征描述和分期。在使用前列腺MRI评估原发性前列腺癌以及PET CT进行前列腺癌分期和复发分期方面正在发生变化。本综述从多学科角度阐述了前列腺MRI和分子成像在前列腺癌中的作用。
